On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...
(Beyond Pesticides, December 17, 2025) In a 50-plus page opinion, the United States Court of Appeals for the Ninth Circuit ruled in October for the plaintiffs on providing general public access to ...
Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from the Government of Canada.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results